-
Mashup Score: 1Drug Shortages - 1 year(s) ago
ASCO Resources Related to Drug Shortages Please see @ASCO on Twitter for the most rapid updates on the availability of cisplatin and carboplatin. The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below. If you have comments, concerns, suggestions for best practices, etc. pertaining to drug shortage,…
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Open Comment of Guidelines - 1 year(s) ago
Open comment allows for key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication.
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
We’re accepting comments on our draft guideline, "Systemic Therapy in Men with Metastatic Castration-Resistant #ProstateCancer." Submit feedback to us by July 31: https://t.co/Rm5uRZqTpT #pcsm https://t.co/YvwPThv3E5
-
-
Mashup Score: 3Drug Shortages - 1 year(s) ago
ASCO Resources Related to Drug Shortages Please see @ASCO on Twitter for the most rapid updates on the availability of cisplatin and carboplatin. The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below. If you have comments, concerns, suggestions for best practices, etc. pertaining to drug shortage,…
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
RT @jrgralow: Cisplatin update - new supply available. For more info: https://t.co/vrCgE2Limn
-
-
Mashup Score: 1Drug Shortages - 1 year(s) ago
ASCO Resources Related to Drug Shortages Please see @ASCO on Twitter for the most rapid updates on the availability of cisplatin and carboplatin. The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below. If you have comments, concerns, suggestions for best practices, etc. pertaining to drug shortage,…
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet-
Cisplatin update - new supply available. For more info: https://t.co/vrCgE2Limn https://t.co/6Q3BNxmF2s
-
-
Mashup Score: 02024 Medicare Payment Proposal Cuts Conversion Factor 3.36% - 1 year(s) ago
On July 13, 2023, the Centers for Medicare & Medicaid Services (CMS) released its proposed rule for the 2024 Medicare Physician Fee Schedule (PFS) and updates to the Quality Payment Program (QPP). The agency also released the 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule.
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
Initial takeaways from 2024 Medicare payment proposal: • Conversion factor cut 3.36% • Est. +2% overall impact for hematology/oncology • Est. -2% overall impact for radiation oncology Learn more: https://t.co/CBVAOpHmOg #ASCOAdvocacy https://t.co/qDCds9OQmp
-
-
Mashup Score: 1Drug Shortages - 1 year(s) ago
ASCO Resources Related to Drug Shortages Please see @ASCO on Twitter for the most rapid updates on the availability of cisplatin and carboplatin. The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below. If you have comments, concerns, suggestions for best practices, etc. pertaining to drug shortage,…
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet-
Cancer #drugshortage ongoing crisis in the U.S. Platinum chemo critical to maintain high cure rate for #germcelltumors. See https://t.co/tqvMnYAmYu for continued guidance from @ASCO, most recently updated to include #testiscancer (joining bladder, breast, GI, Gyn, H&N, SCLC...) https://t.co/ifbTTHMBtr
-
-
Mashup Score: 20Supportive Care and Treatment Related Issues - 1 year(s) ago
Supportive Care and Treatment Related Issues
Source: ASCOCategories: Latest Headlines, UrologyTweet-
RT @ASCO: We’ve issued a rapid guideline update on cancer #cachexia: https://t.co/JRy7tTtF0c https://t.co/lYcjlmUE8b
-
-
Mashup Score: 31Supportive Care and Treatment Related Issues - 1 year(s) ago
Supportive Care and Treatment Related Issues
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
We’ve issued a rapid guideline update on cancer #cachexia: https://t.co/JRy7tTtF0c https://t.co/lYcjlmUE8b
-
RT @ASCO: We’ve issued a rapid guideline update on cancer #cachexia: https://t.co/JRy7tTtF0c https://t.co/lYcjlmUE8b
-
RT @ASCO: We’ve issued a rapid guideline update on cancer #cachexia: https://t.co/JRy7tTtF0c https://t.co/lYcjlmUE8b
-
-
Mashup Score: 5Drug Shortages - 1 year(s) ago
ASCO Resources Related to Drug Shortages Please see @ASCO on Twitter for the most rapid updates on the availability of cisplatin and carboplatin. The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below. If you have comments, concerns, suggestions for best practices, etc. pertaining to drug shortage,…
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
‼️ New clinical guidance available for #TesticularCancer #GermCell tumors during the current #drugshortages Bookmark https://t.co/mPWChjj3yy for the latest guidance and updates on the availability of cisplatin and carboplatin https://t.co/BB4CHrdA0g
-
-
Mashup Score: 5Leadership Development Program - 1 year(s) ago
An overview of ASCO’s flagship Leadership Development Program timeline and curriculum for the upcoming application cycle, including eligibility criteria for prospective applicants.
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
ICYMI: Apps for our 2024-25 Leadership Development Program are open! This program offers participants a unique opportunity to acquire valuable leadership skills while fostering meaningful connections & receiving mentorship from ASCO leaders. Learn more: https://t.co/Iw8c9wkkdr https://t.co/6Vrsh0ikdY
-
❗❗ Read our clinical guidance for #ovarian cancer #germcell tumors during the current #drugshortages. Bookmark https://t.co/mPWChjj3yy for the latest guidance and updates on the availability of cisplatin and carboplatin #gyncsm https://t.co/bcxWe17uOi